Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Millan Billi (Barcelona, Spain), I. Castellví (Barcelona, Spain), L. Martinez Martinez (Barcelona, Spain), F. Aparicio (Barcelona, Spain), T. Franquet (Barcelona, Spain), O. Sibila Vidal (Barcelona, Spain), D. Castillo Villegas (Barcelona, Spain). Diagnostic value of serum KL-6 in Interstitial Lung Disease: preliminary results from an European cohort.. 2959

Member's Comments

No comment yet.

Related content which might interest you: Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Gender perspective in Interstitial Lung Diseases (ILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial Source: International Congress 2014 – ILDs 3 Year: 2014 Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): Clinical, serological and radiological heterogeneity Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Prognostic and predictive value of E-cathepsin for pulmonary adenocarcinomas in the IALT (International Adjuvant Lung Cancer Trial) Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 The impact of the new Global Lung Function Initiative TLCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018 Year: 2019 Translation and preliminary validation of the KBILD QOL questionnaire to Spanish Source: International Congress 2014 – ILDs 6 Year: 2014 Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch Source: International Congress 2014 – ILDs 2 Year: 2014 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Verification of genetic associations with Scleroderma associated Interstitial Lung Disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Hospitalisation pattern in Interstitial Lung Diseases: a claims data study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Diagnostic contribution of EBUS in Interstitial Lung Desease (excluding Sarcoidosis) Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Validation of the LENT score in Japanese sample: The impact of EGFR-TKI Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015